No Data
No Data
Hold Rating Maintained for 10x Genomics Amid Settlement Gains and Macroeconomic Challenges
Bruker Announces Settlement With 10x Genomics
10x Genomics: Settlement Includes Global Patent Cross-Licenses and Complete Withdrawal of All Legal Proceedings >TXG
Express News | 10X Genomics: Expects Bruker to Pay $68 Mln in Equal Qtrly Installments Between Q3 O 2025 & Q2 2026
10x Genomics Reaches Patent Litigation Settlement With Bruker; Bruker To Pay $68M In Equal Quarterly Installments Between Q3 2025 And Q2 2026 As Well As Ongoing Royalties On Sales Of Spatial Biology Products Through Life Of Licensed Patents
10x Genomics Announces Patent Litigation Settlement Agreement With Bruker